ANALYTE MEASUREMENT AND MANAGEMENT DEVICE AND ASSOCIATED METHODS

• US 20100016700A1
• Filed: 07/17/2009
• Published: 01/21/2010
• Est. Priority Date: 07/18/2008
• Status: Abandoned Application

• Current Assignee: Lifescan Incorporated (Duv Holding Corporation)
• Original Assignee: Lifescan Incorporated (Duv Holding Corporation)
• Inventors: Price, David, Krulevitch, Peter, Sieh, Zara, Shartle, Robert, Horwitz, David, Savage, Donna
• Application Number:
  US12/505,007
• Publication Number:
  US 20100016700A1
• Time in Patent Office: Days
• US Class Current: 600/365
• CPC Class Codes: A61B 5/14532 for measuring glucose, e.g. by tissue impedance measurement
• CPC Class Codes: A61B 5/4839 combined with drug delivery
• CPC Class Codes: G16H 15/00 ICT specially adapted for medical reports, e.g. generation or transmission thereof
• CPC Class Codes: G16H 20/17 delivered via infusion or injection
• CPC Class Codes: G16H 40/63 for local operation
• CPC Class Codes: G16H 40/67 for remote operation
• CPC Class Codes: G16H 50/20 for computer-aided diagnosis, e.g. based on medical expert systems

Abstract

Various embodiments of a diabetes management system are provided. One exemplary system may include an analyte measurement device and a therapeutic agent delivery device. The measurement device includes a measurement unit, display, and first wireless module. The therapeutic agent delivery device has a delivery device housing, delivery mechanism disposed in the housing that delivers a dosage of the agent to the user upon actuation by the user or health care provider, and a second wireless module. The second module, automatically, without prompting from a user or any active input or action by the user, transmits a signal to the first wireless module indicative of: (a) type of therapeutic agent delivered; and (b) amount of therapeutic agent delivered to the user; or (c) type of therapeutic agent device from which the therapeutic agent was administered. Also described are diabetes management devices and methods.

Claims

1. A diabetes management system comprising:

an analyte measurement device including;

a housing;

a processor and memory disposed in the housing;

a measurement unit in communication with the processor to provide a numerical value representing generally an amount of analyte in body fluids;

a display in communication with the processor to display information relating to analyte and the therapeutic agent;

a first wireless module coupled to the processor and memory to store data received by the first wireless module in the memory;

a therapeutic agent delivery device including;

a delivery device housing;

a delivery mechanism disposed in the housing that delivers a dosage of the agent to the user upon actuation by the user or health care provider;

a second wireless module disposed in the housing, the second wireless module being configured to automatically, without prompting or any action from a user, transmits a signal to the first wireless module indicative of;

(a) type of therapeutic agent delivered; and

(b) amount of therapeutic agent delivered to the user;

or

(c) type of therapeutic agent device from which the therapeutic agent was administered.

6. The diabetes management system of one of claims 1 and 2, in which the processor is configured to utilize the numerical value so as to provide dosage recommendation for delivery of therapeutic agent according to one of a plurality of recommended administration protocols.

7. The diabetes management system of one of claims 1 and 2, in which the type of therapeutic agent comprises long-acting insulin, a mixture of different types of insulin, rapid-acting insulin or combinations thereof.

8. The diabetes management system of claim 1 or claim 2, in which the display provides an indication of the user'"'"'s analyte measurement values and therapeutic agent administration history.

10. The diabetes management system of claim 8, in which the plurality of therapeutic agent titration protocols comprise basal initiation, titration, or non-carbohydrate counting multiple-daily-injections for type 2 diabetes users.

11. The diabetes management system of claim 8, in which the health care provider'"'"'s computer receives inputs relating to the user of the analyte measurement device including:

(a) body weight;

(b) frequency of insulin

(c) dosing of insulin.

13. The diabetes management system of claim 10, further comprising an audio output in communication with the processor.

14. The diabetes management system of claim 10, in which the processor is programmed to generate:

(a) a reminder for the user to perform an analyte measurement;

(b) a reminder for the user to perform therapeutic agent delivery to the user in accordance with the recommended administration protocol;

(c) instructions on an amount of therapeutic agent to be used by the user based generally on at least one analyte value as measured by the analyte measurement device; and

(d) an indicator of the user'"'"'s adherence to the recommended administration protocol.

15. The diabetes management system of claim 1 or claim 2, in which the analyte comprises blood glucose and the bodily fluid comprises blood.

16. The diabetes management system of claim 1 or claim 2, in which the analyte measurement device includes a strip port configured to operatively accommodate an analyte test strip.

17. The diabetes management system of claim 1 or claim 2, in which the therapeutic administration protocol comprises at least one of a recommended dosage of the therapeutic agent, type of therapeutic agent, and administration time of the therapeutic agent.

18. The diabetes management system of claim 1 or claim 2, in which the therapeutic administration protocol employs a result of at least one analyte measurement stored in the memory to provide the recommended therapeutic agent dosage and recommended administration time.

19. The diabetes management system of claim 1 or claim 2, in which the memory comprises storage of analyte measurements made by the analyte measurement device along with associated dates and times, the recommended therapeutic agent dosage, the recommended administration time and information related to the actual therapeutic agent dosage and actual administration time in the memory.

20. The diabetes management system of claim 1 or claim 2, in which the memory comprises storage of at least one flag that indicates when analyte measurements and therapeutic agent dosages occurred in relationship to user meals in the memory.

21. The diabetes management system of claim 1 or claim 2, further including an alarm module configured to alert a user when the medical delivery device communication module has not detected user-activated administration of the therapeutic agent.

22. The diabetes management system of claim 1 or claim 2, in which the therapeutic agent is selected from the group consisting essentially of medications for diabetes, medications for metabolic management, inflammation management, hormonal therapy agents, oncology agents, pain management agents, regenerative medicine agents, and a combination thereof.

23. The diabetes management system of claim 1 or claim 2, further comprising a user interface on one of the analyte measurement device and the analyte delivery device, and in which the processor and display are configured to prompt a user to confirm administration of therapeutic agent via the user interface.

24. The diabetes management system of claim 1 or claim 2, in which the memory comprises storage to store date and time in a user-selected time zone;

a compliance table that includes at least a record of missed therapeutic administrations; and

an actual initiation date of the therapeutic protocol.

25. The diabetes management system of claim 1 or claim 2, in which each of the first and second wireless module comprises a transmitter and receiver module.

26. The diabetes management system of claim 1 or claim 2, in which the first wireless module comprises a transmitter and receiver module and the second wireless module comprises a transmitter.

27. The diabetes management system of claim 1 or claim 2, in which the therapeutic administration protocol comprises treat to target, 4T Titration Protocol, insulation titration or Basal/Bolus Titration protocol.

2. A diabetes management system comprising:

an analyte measurement device including;

a housing;

a processor and memory disposed in the housing;

a measurement unit in communication with the processor to provide a numerical value representing generally an amount of analyte in body fluids;

a display in communication with the processor to display information relating to analyte and the therapeutic agent;

a first wireless module coupled to the processor and memory to store data received by the first wireless module in the memory;

a therapeutic agent delivery device including;

a delivery device housing;

a delivery mechanism disposed in the housing that delivers a dosage of the agent to the user upon actuation by the user or health care provider;

a second wireless module disposed in the housing and coupled to the delivery mechanism, the second wireless module, upon prompting or by an action from a user, transmits a signal to the first wireless module indicative of;

(a) type of therapeutic agent delivered; and

(b) amount of therapeutic agent delivered to the user;

or

(c) type of therapeutic agent device from which the therapeutic agent was administered; and

a health care provider computer in communication with the analyte measurement device to prescribe one of a plurality of therapeutic agent titration protocols to the memory of the analyte measurement device.

3. A diabetes management device comprising:

a housing;

a processor and memory disposed in the housing, the memory including a plurality of therapeutic administration protocols loaded into the memory from an external source that relates a dosage administration to one or more analyte amount;

a measurement unit in communication with the processor to provide a numerical value representing generally an amount of analyte in body fluids;

a display in communication with the processor to display information relating to measured amount of analyte and type of therapeutic agent from the plurality of protocols.

4. The diabetes management device of claim 3, further comprising a first wireless module coupled to the processor and memory to store data received by the first wireless module in the memory;

and

5. The diabetes management device of claim 4, further comprising a therapeutic agent delivery device including:

a delivery device housing;

a second wireless module disposed in the housing and configured the second wireless module upon prompting or by an action from a user, transmits a signal to the first wireless module indicative of;

(a) type of therapeutic agent delivered; and

(b) amount of therapeutic agent delivered to the user;

or

(c) type of therapeutic agent device from which the therapeutic agent was administered.

9. The diabetes management device of claim 3, further comprising a health care provider computer in communication with the device to prescribe one of a plurality of therapeutic agent titration protocols to the memory of the device.

28. A method of managing diabetes of a user, the method comprising:

selecting a therapeutic administration protocol in accordance with therapeutic requirements of the diabetic user;

transferring the therapeutic administration protocol to an analyte measurement device assigned to the user;

confirming delivery of therapeutic agent to the user in accordance with the therapeutic administration protocol; and

generating a plurality of prompts to the user including;

(a) a reminder to measure analyte at a specified time;

(b) a reminder to administer a recommended dosage of therapeutic agent within a specified time frame; and

(c) a report of compliance of the user to the therapeutic administration protocol.

29. The method of claim 28, in which the selecting comprises:

entering a set up mode;

selecting one of a plurality of therapeutic administration protocols, and upon selection of;

(a) a long acting protocol, selecting a body weight range and confirming a starting dosage, maximum dosage, fasting measurement and specified time for delivery of the therapeutic agent;

(b) a premix protocol, selecting a frequency of delivery of therapeutic agent and confirming the frequency and specified time for delivery of the therapeutic agent;

or

(c) a multiple daily administration protocol, selecting a largest meal during a specified time duration for rapid acting therapeutic agent initiation and confirming the dosage of a long acting therapeutic agent at a specified time.

30. The method of claim 28, in which the generating comprises displaying at least one of:

(a) a result of the analyte measurement;

(b) the dosage specified;

or

(c) a summary of the dosage administered at one or more specified time slots;

(d) a summary of analyte measurements; and

(e) a summary of missed dosing and missed analyte measurements.

31. The method of claim 28, in which the confirming comprises prompting the user to confirm delivery of the agent.

32. The method of claim 28, in which the confirming comprises automatically storing, without prompting the user, the dosage of agent delivered and approximate time of delivery.

33. A method of operating an analyte measurement device having a plurality of therapeutic administration protocols stored in a memory of the device, the memory in communication with a processor, the processor configured to interface with user inputs and provide various output information, the method comprising:

accessing a selection menu generated by the processor with protocols loaded into the memory from an external source;

selecting one therapeutic administration protocol from the plurality of therapeutic administration protocols; and

outputting dosage information for therapeutic agent to be administered to a user based on one or multiple analyte amounts or concentration values stored in the memory.

34. The method of claim 33, in which the accessing comprises:

logging in to the selection menu via a password protected interface.

35. The method of claim 33, in which the accessing comprises:

logging in to the selection menu via a security token.